It has been shown that JAK2 mRNA expression is associated with favorable outcomes in breast cancer, particularly in recurrence-free survival, with a more pronounced protective effect in specific subtypes, such as triple-negative breast cancer [43]. Here, JAK2 is linked to breast carcinoma.